Cartesian reports positive results from Phase IIb myasthenia gravis trial [Yahoo! Finance]
Cartesian Therapeutics Strengthens Board of Directors with Appointment of Kemal Malik [Yahoo! Finance]
Cartesian Therapeutics Strengthens Board of Directors with Appointment of Kemal Malik
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) was downgraded by analysts at Oppenheimer Holdings Inc. from an "outperform" rating to a "market perform" rating.
Cartesian Therapeutics Announces $130 Million Private Placement Equity Financing [Yahoo! Finance]